Elevated CRP levels are associated with severe skin and skin structure infections: Exploratory analysis in a double-blind, randomized trial comparing ceftobiprole with vancomycin for treatment of skin infections

被引：0
|
作者：
Strauss, Richard
Noel, Gary
机构：
来源：
INFLAMMATION RESEARCH | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：S296 / S296
页数：1
相关论文
共 50 条
  • [41] Cost-Effectiveness of Telavancin versus Vancomycin for Treatment of Complicated Skin and Skin Structure Infections
    Laohavaleeson, Somvadee
    Barriere, Steven L.
    Nicolau, David P.
    Kuti, Joseph L.
    PHARMACOTHERAPY, 2008, 28 (12): : 1471 - 1482
  • [42] A Randomized, Double-Blind Phase 2 Study Comparing the Efficacy and Safety of an Oral Fusidic Acid Loading-Dose Regimen to Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
    Craft, J. Carl
    Moriarty, Susan R.
    Clark, Kay
    Scott, Drusilla
    Degenhardt, Thorsten P.
    Still, J. Gordon
    Corey, G. Ralph
    Das, Anita
    Fernandes, Prabhavathi
    CLINICAL INFECTIOUS DISEASES, 2011, 52 : S520 - S526
  • [43] A clinical, prospective, randomized, double-blind trial comparing skin whitening complex versus hydroquinone in the treatment of melasma
    Mateus, Andreia
    Bravo, Bruna
    Issa, Maria Claudia
    Spinelli, Leticia
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB87 - AB87
  • [44] A Randomized, Evaluator-Blind, Phase 2 Study Comparing the Safety and Efficacy of Omadacycline to Those of Linezolid for Treatment of Complicated Skin and Skin Structure Infections
    Noel, Gary J.
    Draper, Michael P.
    Hait, Howard
    Tanaka, S. Ken
    Arbeit, Robert D.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (11) : 5650 - 5654
  • [45] Skin graft donor site and use of polydeoxyribonucleotide as a treatment for skin regeneration: A randomized, controlled, double-blind, clinical trial
    De Aloe, G
    Rubegni, P
    Biagioli, M
    Taddeucci, P
    Fimiani, M
    WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE, 2004, 16 (08): : 258 - 263
  • [46] TREATMENT OF HOSPITALIZED-PATIENTS WITH COMPLICATED SKIN AND SKIN-STRUCTURE INFECTIONS - DOUBLE-BLIND, RANDOMIZED, MULTICENTER STUDY OF PIPERACILLIN-TAZOBACTAM VERSUS TICARCILLIN-CLAVULANATE
    TAN, JS
    WISHNOW, RM
    TALAN, DA
    DUNCANSON, FP
    NORDEN, CW
    HANNA, C
    CHRISTOU, N
    BERNSTEIN, J
    MARSH, P
    SMITH, M
    SAPICO, F
    MURRAY, G
    CROCKERSMITH, LL
    SEGRETI, J
    GENTRY, L
    CULLISON, J
    SATHE, S
    LOW, I
    LAMOTHE, F
    MERSEY, J
    DALL, L
    LAVERDIERE, M
    MITCHELL, J
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (08) : 1580 - 1586
  • [47] COMPARATIVE, DOUBLE-BLIND-STUDY OF ORAL CIPROFLOXACIN AND INTRAVENOUS CEFOTAXIME IN SKIN AND SKIN STRUCTURE INFECTIONS
    RAMIREZRONDA, CH
    SAAVEDRA, S
    RIVERAVAZQUEZ, CR
    AMERICAN JOURNAL OF MEDICINE, 1987, 82 (4A): : 220 - 223
  • [48] Efficacy and safety of delafloxacin, ceftaroline, ceftobiprole, and tigecycline for the empiric treatment of acute bacterial skin and skin structure infections: A network meta-analysis of randomized controlled trials
    Alhifany, Abdullah A.
    Bifari, Nisrin
    Alatawi, Yasser
    Malik, Saad U.
    Almangour, Thamer A.
    Altebainawi, Ali F.
    Alshammari, Thamir M.
    Alotaibi, Amal F.
    Mahrous, Ahmad J.
    Alshehri, Fahad S.
    Cheema, Ejaz
    SAUDI PHARMACEUTICAL JOURNAL, 2022, 30 (03) : 195 - 204
  • [49] Evidence Associated with the Use of Oxazolidinones in the Treatment of Skin and Skin Structure Infections: A Retrospective Study
    Santos, Tiago
    Carvalho, Rui
    Abreu, Miguel Araujo
    Reis, Ernestina
    Couto De Carvalho, Andre
    ACTA MEDICA PORTUGUESA, 2020, 33 (02): : 150 - 150
  • [50] Evidence Associated with the Use of Oxazolidinones for the Treatment of Skin and Skin Structure Infections: A Retrospective Study
    Goncalves-Pereira, Joao
    Froes, Filipe
    Santos, Fernanda Paula
    Antao, Helena Sofia
    Guimaraes, Joao Paulo
    ACTA MEDICA PORTUGUESA, 2019, 32 (06): : 453 - 458
12345